Pharmacokinetics and Toxicity Testing

References

• Zbinden G. Comparative and pharmacokinetic toxicity. Progress in Toxicology, Special Topics. Springer-Verlag, Berlin 1976; Vol. 2: 44
   Google Scholar
• Zbinden G. Application of basic concepts to research in toxicology. Pharmacol. Rev. 1979; 30: 605
   Web of Science ®Google Scholar
• Zbinden G., Flury-Roversi M. Significance of the LD50test for the toxicological evaluation of chemical substances. Arch. Toxicol. 1981; 47: 77
   PubMed Web of Science ®Google Scholar
• Malmfors T. Toxicology as science. Trends Pharmacol. Sci. 1981; 2(1)I
   Web of Science ®Google Scholar
• Dayan A. D. The troubled toxicologist. Trends Pharmacol. Sci. 1981; 2(11)I
   Web of Science ®Google Scholar
• Aldridge W. N. Mechanisms of toxicity; new concepts are required in toxicology. Trends Pharmacol. Sci. 1981; 2(9)228
   Web of Science ®Google Scholar
• Graham-Smith D. Reported in Scrip May 13, 1981, No. 590: 4
   Google Scholar
• Graham-Smith D. Problems facing a regulatory authority. Risk-Benefit Analysis in Drug Research, J. F. Cavalla. MTP Press, LancasterU.K. 1981; 51
   Google Scholar
• Brimblecombe R. W. The impact of regulation on the discovery of new medicines. Trends Pharmacol. Sci. 1981; 2(2)I
   Web of Science ®Google Scholar
• Dayan A. D. The relative worth of animal testing. Risk-Benefit Analysis in Drug Research, J. F. Cavalla. MTP Press, LancasterU.K. 1981; 97
   Google Scholar
• O'Reilly W. J. Pharmacokinetics in drug metabolism and toxicology. Can. J. Pharm. Sci. 1972; 7: 66
   Web of Science ®Google Scholar
• Withey J. R. Pharmacokinetic principles. Proc. Ist Int. Congr. Toxicology, G. L. Plaa, W. A. M. Duncan. Academic Press, New York 1978; 97
   Google Scholar
• Garrett E. R. The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics. Prog. Drug Res. 1977; 21: 105
   PubMedGoogle Scholar
• Andersen M. E. Saturable metabolism and its relationship to toxicity. Crit. Rev. Toxicol. 1981; 9: 105
   PubMed Web of Science ®Google Scholar
• Hayes W. J., Jr. Tests for detecting and measuring long-term toxicity. Essays in Toxicology. Academic Press, New York 1972; Vol. 3: 65
   Google Scholar
• Smith C. G., Poutsiaka J. W., Schreiber E. C. Problems in predicting drug effects across species lines. J. Int. Med. Res. 1973; 1: 489
   Google Scholar
• Albert A. Selective Toxicity, 2nd ed. John Wiley & Sons, New York 1960, chap. 1
   Google Scholar
• Mellett L. B. Comparative drug metabolism. Prog. Drug. Res. 1969; 13: 136
   PubMedGoogle Scholar
• Dedrick R. L. Animal scale up. J. Pharmacokinet. Biopharm. 1973; 1: 435
   PubMedGoogle Scholar
• Dedrick R. L., Bischoff K. B. Species similarities in pharmacokinetics. Fed. Proc. 1980; 39: 54
   PubMedGoogle Scholar
• Rentsch G. Pharmacokinetic systems for interpreting long-term experiments. Proc. Eur. Soc. Toxicol. 1974; 15: 323
   Google Scholar
• Cohen Y. Radionuclide-labelled compounds in the approach of pharmacokinetics. Proc. Eur. Soc. Toxicol. 1973; 14: 20
   Google Scholar
• Hottendorf G. H., Van Harken D. R., Madissoo H., Cabana B. E. Pharmacokinetic considerations in toxicology. Proc. Eur. Soc. Toxicol. 1976; 17: 255
   Google Scholar
• Monro A. M. Pharmacokinetics. Symp. Proc. Ser. No. 7. Institute of Mathematics and its Applications, London 1975; 46
   Google Scholar
• Smyth R. D., Hottendorf G. H. Applications of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol. Appl. Pharmacol. 1980; 53: 179
   PubMed Web of Science ®Google Scholar
• Gehring P. J., Watanabe P. G., Blau G. E. Pharmacokinetic studies in evaluation of the toxicological and environmental hazard of chemicals. Advances in Modern Toxicology, M. A. Mehlman, R. E. Shapiro, H. Blumenthal. John Wiley & Sons, New York 1976; Vol. 1: 195, (Part 1)
   Google Scholar
• Tuey D. B. Toxicokinetics. Introduction to Biochemical Toxicology, E. Hodgson, F. E. Guthrie. Blackwell Scientific, Oxford 1980; 40
   Google Scholar
• Karlog O., Neilsen P., Rasmussen F. Toxicokinetics. Arch. Toxicol. 1978; 55, Suppl. 1
   Google Scholar
• Health and Safety Commission, Consultative document. Notification of New Substances, Draft Regulations and Approved Codes of Practice. Her Majesty's Stationery Office, London 1981
   Google Scholar
• Jusko W. J. Pharmacokinetic principles in chemical teratology. Proc. Eur. Soc. Toxicol. 1973; 14: 9
   Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Biochem. Pharmacol. 1974; 23: 2785
   PubMed Web of Science ®Google Scholar
• Gillette J. R. A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Biochem. Pharmacol. 1974; 23: 2927
   PubMed Web of Science ®Google Scholar
• Von Hammer R., Jauch R., Koss F. W. Pharmacokinetische untersuchungen als hilfsmittel zur interpretation des verlaufs von toxizitatsprufungen. Arzneim-Forsch./Drug Res. 1981; 28: 1978
   Google Scholar
• Filser J. G., Bolt H. M. Inhalation pharmacokinetics based on gas uptake studies. Arch. Toxicol. 1981; 47: 279
   PubMed Web of Science ®Google Scholar
• Goldenthal E. I. (1968) FDA Papers. May 3, 1968. U.S. Food and Drug Administration, Washington, D.C.
   Google Scholar
• EEC Commission. Proposal for a Council Recommendation Concerning Tests Relating to the Placing on the Market of Proprietary Medicinal Products. Off. J. Eur. Communities December, 1980, No. C 355/6–29
   Google Scholar
• Wallach D. P., Thomas R. C. Psicofuramine. VIII. Some pharmacological observations. Antibiot. Chemother. 1959; 9: 722
   Google Scholar
• Handschumacher R. E., Creasey W. A., Fink M. E., Calabresi P., Welch A. D. Pharmacological and clinical studies with triacetyl-6-azauridine. Cancer Chemother. Rep. 1962; 16: 267
   PubMedGoogle Scholar
• Dreyfuss J., Shaw J. M., Ross J. J. Absorption of Nadolol by mice, rats, hamsters, rabbits, dogs, monkeys and man. Xenobiotica 1978; 8: 503
   PubMed Web of Science ®Google Scholar
• Reeves P. R., Barnfield D. J., Longshaw S., McIntosh D. A. D., Winrow M. J. Disposition and metabolism of atenolol in animals. Xenobiotica 1978; 8: 305
   PubMed Web of Science ®Google Scholar
• Steiner K., Garbe A., Diekmann H. W., Nowak H. The fate of praziquantel in the organism. Eur. J. Drug Metab. Pharmacokinet. 1976; 1: 85
   Google Scholar
• Hawkins D. R., Weston K. T., Chasseaud L. F., Darragh A., O'Kelly A. The absorption and excretion of14C-mecinarone in rat, dog and man. Eur. J. Drug Metab. Pharmacokinet. 1980; 5: 135
   PubMedGoogle Scholar
• Chausseaud L. F., Hawkins D. R., Fry B. J., Lewis J. D., Saggers V. H., Sword I. P. Metabolism of a cinnamoylpiperazine. Xenobiotica 1974; 4: 393
   PubMedGoogle Scholar
• Lesser J. M., Israili Z. H., Davis D. C., Dayton P. G. Hydrazaline-14C metabolism and disposition. Drug Metab. Disp. 1974; 2: 351
   PubMed Web of Science ®Google Scholar
• Cameron B. D., Chasseaud L. F., Hawkins D. R., Taylor T. Metabolism of a cinnamoylpiperazine. Xenobiotica 1976; 6: 441
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Duncan A. E. W., Deluna F. A., Hucker H. B., Gruber V. F., Vandenheuvel W. J. A. Metabolism of timolol. Drug Metab. Disp. 1975; 3: 361
   PubMed Web of Science ®Google Scholar
• Wood B. A., Stopher D. A., Monro A. M. Metabolism of tolamolol in the mouse, rat, guinea pig, rabbit and dog. Xenobiotica 1975; 5: 183
   PubMed Web of Science ®Google Scholar
• Tocco D. J., Breault G. O., Zacchei A. G., Steelman S. L., Perrier C. V. Metabolism of MK-647. Drug Metab. Disp. 1975; 3: 453
   PubMed Web of Science ®Google Scholar
• Grindel J. M., O'Neill P. J., Yorgey K. A., Schwartz M. H., McKown L. A., Migdalof B. H., Wu W. Disposition and pharmacokinetics of zomepirac. Drug Metab. Disp. 1980; 8: 343
   PubMed Web of Science ®Google Scholar
• Warrander A., Metcalf R., Fromson J. M. Metabolism of fendosal. Drug Metab. Disp. 1981; 9: 161
   PubMedGoogle Scholar
• Zacchei A. G., Weidner L. L., Besselaar G. H., Raftery E. B. Physiological disposition and metabolic fate of a new antiarrythmic agent a,a-dimethyl-4(a,a,β,β-tetrafluorophenetyl) benzylamine in the rat, dog, monkey, baboon and man. Drug Metab. Disp. 1976; 4: 387
   PubMedGoogle Scholar
• Benziger D. P., Balfour K., Clemans S., Edelson J. Metabolism of cyclindole. Drug Metab. Disp. 1977; 5: 239
   PubMed Web of Science ®Google Scholar
• Case D. E., Illston H., Reeves P. R., Shuker B., Simons P. Metabolism of viloxazine in animals. Xenobiotica 1975; 5: 83
   PubMed Web of Science ®Google Scholar
• Forshell G. P. Lofepramine kinetics in rat, dog and man. Xenobiotica 1977; 7: 153
   PubMed Web of Science ®Google Scholar
• Sisenwine S. F., Tio C. O., Ruelius H. W. Iprindole disposition in several species. Xenobiotica 1979; 9: 237
   PubMed Web of Science ®Google Scholar
• Mayo B. C., Hawkins D. R., Humpel M., Chasseaud L. F., Girkin R. Lormetazepan biotransformation in animals. Xenobiotica 1980; 10: 413
   PubMed Web of Science ®Google Scholar
• Delong A. F., Smyth R. D., Polk A., Nayak R. K., Martin G., Douglas G. H., Cantwell N. H. R. Comparative metabolism of fenclorac. Drug Metab. Disp. 1977; 5: 122
   PubMed Web of Science ®Google Scholar
• Illing H. P. A., Fromson J. M. Isoxepac disposition and metabolism. Drug Metab. Disp. 1978; 6: 510
   PubMed Web of Science ®Google Scholar
• Janssen F. W., Kirkman S. K., Knowles J. A., Ruelius H. W. Disposition of oxaprozin. Drug Metab. Disp. 1978; 6: 465
   PubMed Web of Science ®Google Scholar
• Mroszczak E. J., Lee F. W. Tiopinac disposition. Drug Metab. Disp. 1980; 8: 415
   PubMed Web of Science ®Google Scholar
• Risdall P. C., Adams S. S., Crampton E. L., Marchant B. Metabolism of flurbiprofen. Xenobiotica 1978; 8: 691
   PubMed Web of Science ®Google Scholar
• Taylor J. A., Jr. Benzylthio-5-trifluoromethyl benzoic acid. Xenobiotica 1973; 3: 151
   PubMed Web of Science ®Google Scholar
• Hucker H. B., Stauffer S. C., Balletto A. J., White S. D., Zacchei A. G., Arison B. H. Disposition and metabolism of cyclobenzaprine. Drug Metab. Disp. 1978; 6: 659
   PubMed Web of Science ®Google Scholar
• Turnbull L. B., Teng L., Newman J., Bruce R. B., Maynard W. R. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methyl pyrrolidine [14C]-carboxamide in the rat, dog and man. Drug Metab. Disp. 1976; 4: 379
   PubMed Web of Science ®Google Scholar
• Greenslade D., Havler M. E., Humphrey M. J., Jordan B. J., Lewis C. J., Rance M. J. Metabolism of tolmesoxide. Xenobiotica 1981; 11: 89
   PubMed Web of Science ®Google Scholar
• Taylor D. C., Cresswell P. R., Bartlett D. C. Cimetidine metabolism. Drug Metab. Disp. 1978; 6: 21
   PubMed Web of Science ®Google Scholar
• Taylor D. C., Cresswell P. R., Pepper E. S. Metiamide metabolism. Drug Metab. Disp. 1979; 7: 393
   PubMed Web of Science ®Google Scholar
• Tocco D. J., DeLuna F. A., Duncan A. E. W., Walker R. W., Arison B. H., Vandenheuval W. J. A. Physiological disposition and metabolism of 2-aminomethyl-4-(1,1 -dimethyl ethyl)-6-iodophenol hydrochloride. Drug Metab. Disp. 1979; 7: 330
   PubMed Web of Science ®Google Scholar
• Chu N. I., Amos B. A., Tokes L., Maddox M. L., Matin S. B., Hama K. M., Patterson J. W., Wagner P. J., Bell J. P., Chaplin M. D. Disposition of flunisolide. Drug Metab. Disp. 1979; 7: 81
   PubMed Web of Science ®Google Scholar
• Fromson J. M., Pearson S., Bramah S. Metabolism of tamoxifen by animals. Xenobiotica 1973; 3: 693
   PubMed Web of Science ®Google Scholar
• Daniel J. W., James G. W. L., Rowlands D. A., Taylor J. B. Comparative metabolism of azipranone. Xenobiotica 1978; 8: 321
   PubMed Web of Science ®Google Scholar
• Jeffery D. J., Jones K. H., Langley P. F. The metabolism of talampicillin in rat, dog and man. Xenobiotica 1978; 8: 419
   PubMed Web of Science ®Google Scholar
• Smith D. A., Neale M. G. Suitability of species selected for the chronic toxicity testing of proxicromil. Toxicol. Lett. 1980; 47, Spec. 1
   Google Scholar
• Schwartz D. E., Jordan J. C., Vetter W., Oesterhelt G. Metabolism of ornidazole in animals and man. Xenobiotica 1979; 9: 571
   PubMed Web of Science ®Google Scholar
• Zacchei A. G., Wishousky T. I., Watson L. S. The physiological disposition of (2-cyclopentyl-6,7-dichloro-2-methyl-1 oxo-5-indananyloxy) acitic acid in the rat, dog, rhesus monkey and baboon. Drug Metab. Disp. 1978; 6: 313
   PubMed Web of Science ®Google Scholar
• Houston J. B., Wood S. G. Gastrointestinal absorption of drugs and other xenobiotics. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. John Wiley & Sons, New York 1980; 57
   Google Scholar
• Barry R. E. Length and absorptive surface area apportionment of segments of the hind gut for eight species of small mammals. J. Mammol. 1977; 58: 419
   PubMed Web of Science ®Google Scholar
• Orwig B. A., Dugger H. A., Bhuta S. I., Talbot K. C., Schwarz H. J. Biotransformation of fluproquazone in man and several animal species. Arzneim-Forsch./Drug Res. 1981; 31: 904
   PubMed Web of Science ®Google Scholar
• Watanabe J., Okabe H., Ichihashi T., Mizojiri K., Yamada H., Yamamoto R. Gastric emptying rate constants after oral administration of drug solution to mice, rats and rabbits. Chem. Pharm. Bull. 1977; 25: 2147
   PubMed Web of Science ®Google Scholar
• Theodorakis M. C. External scintigraphy for gastric emptying in Beagles. Am. J. Physiol. 1980; 239: G39
   Google Scholar
• Chiou W. L., Riegelman S., Amberg J. R. Complications in using rabbits for the study of oral absorption. Chem. Pharm. Bull. 1969; 17: 2170
   PubMed Web of Science ®Google Scholar
• Yamato C., Takahashi T., Fujita T. Intestinal absorption of trazodone. Xenobiotica 1976; 6: 521
   PubMed Web of Science ®Google Scholar
• Bungay P. M., Dedrick R. L., Matthews H. B. Enteric transport of chlordecone in the rat. J. Pharmacokinet. Biopharm. 1981; 9: 309
   PubMedGoogle Scholar
• Bridges J. W., Dent J. G., Johnson P. Drug effects on rat gastric emptying. Life Sci. 1976; 18: 97
   PubMed Web of Science ®Google Scholar
• Melamed S., Carlson G. R., Moss J. N., Belair E. J., Tansy M. F. GI pharmacology of polyethyleneimine 1: effect on gastric emptying in rats. J. Pharm. Sci. 1977; 66: 899
   PubMed Web of Science ®Google Scholar
• Yanai Y., Nakai Y., Nakajima N., Tanayama S. Metabolism of ethyltetrazolylchromone. Xenobiotica 1979; 9: 33
   PubMedGoogle Scholar
• Tattersall M. L. Personal communication 1981
   Google Scholar
• Franklin R. A. Gastric emptying and plasma meptazinol. Br. J. Pharmacol. 1977; 59: 565
   PubMed Web of Science ®Google Scholar
• Levy G., Gibaldi M., Procknal J. A. Effect of an anticholinergic agent on riboflavin absorption in man. J. Pharm. Sci. 1972; 61: 798
   PubMed Web of Science ®Google Scholar
• Harris P. A., Riegelman S. Influence of the route of administration on the area under the plasma concentration time curve. J. Pharm. Sci. 1969; 58: 71
   PubMed Web of Science ®Google Scholar
• Routledge P. A., Shand D. G. Presystemic drug elimination. Ann. Rev. Pharmacol. Toxicol. 1979; 19: 447
   PubMed Web of Science ®Google Scholar
• Higuchi S., Shiobara Y. Pharmacokinetics of nicardipine. Xenobiotica 1980; 10: 447
   PubMed Web of Science ®Google Scholar
• Boyd E. M. Route of drug administration. Predictive Toxicometrics. Bristol Scientechnica, BristolU.K. 1972; 137
   Google Scholar
• Worden A. N., Harper K. H. Oral toxicity as influenced by method of administration. Proc. Eur. Soc. Toxicol. 1964; 4: 107
   Google Scholar
• Mead B., Patterson L. H., Smith D. A. The disposition of FPL 55712 acid in rat and dog. J. Pharm. Pharmacol. 1981; 33: 682
   PubMed Web of Science ®Google Scholar
• Tam Y. K., Axelson J. E., McErlane B., Ongley R., Price J. D. E. Non-linear metoclopramide kinetics. J. Pharm. Exp. Ther. 1981; 217: 764
   PubMedGoogle Scholar
• Nies A. S., Evans G. H., Shand D. G. Regional hemodynamic effects of propranolol in the unanaesthetised primate. Am. Heart J. 1973; 85: 97
   PubMed Web of Science ®Google Scholar
• Colombo T., Broggini M., Garattini S., Donelli M. G. Differential adriamycin distribution to blood components. Eur. J. Drug. Metab. Pharmacokinet. 1981; 6: 115
   PubMedGoogle Scholar
• Fremstad D., Jacobsen S., Lunde K. M. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats. Acta Pharmacol. Toxicol. 1977; 41: 161
   PubMedGoogle Scholar
• Klotz U., Golbs E. The pharmacokinetics and tissue distribution of the new antiarrhythmic agent, lorcainide in rats. Arzneim- Forsch/Drug Res. 1980; 30: 619
   PubMed Web of Science ®Google Scholar
• Kaplan S. A., Alexander K., Jack M. L., Puglisi C. V., De Silva J. A. F., Lee T. L., Weinfeld R. E. Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog. J. Pharm. Sci. 1974; 63: 527
   PubMed Web of Science ®Google Scholar
• Bekersky I., Maggio A. C., Mattaliano V., Boxenbaum H. G., Maynard D. E., Cohn P. D., Kaplan S. A. Influence of phenobarbitone on the disposition of clonazepam and antipyrine in the dog. J. Pharmacokinet. Biopharm. 1977; 5: 507
   PubMedGoogle Scholar
• Griffiths R., Lee R. M., Taylor D. C. Kinetics of cimetidine in man and experimental animals. Cimetidine, W. L. Borland, F. Simkins. Excerpta Medica, Amsterdam 1977; 38
   Google Scholar
• Pedersen P. V., Miller R. Pharmacokinetics and bioavailability of cimetidine in humans. J. Pharm. Sci. 1980; 69: 394
   PubMed Web of Science ®Google Scholar
• Halkin H., Meffin P., Melmon K. L., Rowland M. Lidocaine and metabolite levels. Clin. Pharm. Ther. 1975; 17: 669
   PubMed Web of Science ®Google Scholar
• Tucker G. T., Wiklund L., Berlin-Wahlen A., Mather L. E. Hepatic clearance of local anaesthetics in man. J. Pharmacokinet. Biopharm. 1977; 5: 111
   PubMedGoogle Scholar
• Heykants J., Knaeps A., Meuldermans W., Michiels M. On the pharmacokinetics of domperidone in animals and man. Eur. J. Drug Metab. Pharmacokinet. 1981; 6: 27
   PubMedGoogle Scholar
• Johannessen W., Gadeholt G., Aarbakke J. Ether anaesthesia and drug kinetics. J. Pharm. Pharmacol. 1981; 33: 365
   PubMed Web of Science ®Google Scholar
• Dean M., O'Donnell L., Penglis S., Stock B. Antipyrine pharmacokinetics in the pregnant rat. Drug Metab. Disp. 1980; 8: 265
   PubMed Web of Science ®Google Scholar
• Ossenberg F. W., Peignoux M., Bourdiau D., Benhamou J. P. Pentobarbital pharmacokinetics in the normal and in the hepatectomized rat. J. Pharm. Exp. Ther. 1975; 194: 111
   PubMed Web of Science ®Google Scholar
• Buice R. G. Effect of hyperbilirubinemia on the pharmacokinetics of pentobarbital in the rat. Res. Commun. Chem. Pathol. Pharmacol. 1978; 21: 237
   PubMedGoogle Scholar
• Lukas G., Kunjbala H. V., Brindle S. D., LeSher A. R., Wagner W. E. Biological disposition of sodium dichloroacetate in animals and humans. J. Pharm. Sci. 1980; 69: 419
   PubMed Web of Science ®Google Scholar
• Parke D. V. The metabolism and chemobiokinetics of environmental chemicals. The Principles and Methods in Modern Toxicology, C. L. Galli, S. D. Murphy, R. Paolletti. Elsevier, Amsterdam 1980; 85
   Google Scholar
• Jansen A. B. A. Total radioactivity half lives. Drug Metab. Disp. 1979; 7: 350
   PubMed Web of Science ®Google Scholar
• Evans G. H., Nies A. S., Shand D. G. Plasma binding of propranolol. J. Pharm. Exp. Ther. 1973; 186: 114
   PubMed Web of Science ®Google Scholar
• Singhvi S. M., Kripalani K. J., Dean A. V., Reim G. R., Kulesza J. S., Meeker F. S., Ross J. J., Shaw J. M., Migdalof B. H. Absorption and bioavability of captopril in mice and rats after administration by gavage and in the diet. J. Pharm. Sci. 1981; 70: 885
   PubMed Web of Science ®Google Scholar
• Welling P. G. Drug kinetics. Foreign Compound Metabolism in Mammals. Chemical Society, London 1972; Vol. 2: 412
   Google Scholar
• Perrier D., Gibaldi M. Influence of first pass effect on the systemic availability of propoxyphene. J. Clin. Pharmacol. 1972; 12: 449
   Web of Science ®Google Scholar
• Giacomini K. M., Nakeeb S. M., Levy G. Pharmacokinetic studies of propoxyphene. J. Pharm. Sci. 1980; 69: 786
   PubMed Web of Science ®Google Scholar
• Clark B., Neale M. G. Hepatic and renal clearance of sodium cromoglycate. J. Pharm. Pharmacol. 1981; 33: 744
   PubMed Web of Science ®Google Scholar
• Data J. L., Rane A., Gerkens J., Wilkinson G. R., Nies A. S., Branch R. A. Indomethacin and frusemide. J. Pharm. Exp. Ther. 1978; 206: 431
   PubMed Web of Science ®Google Scholar
• Branch R. A., Shand D. G., Wilkinson G. R., Nies A. S. The reduction of lidocaine clearance by dl-propranolol. J. Pharm. Exp. Ther. 1973; 184: 515
   PubMed Web of Science ®Google Scholar
• Deboer A. G., Breimer D. D., Pronk J., Gubbens-Stibbe J. M. Rectal bioavailability of lidocaine in rats. J. Pharm. Sci. 1980; 69: 804
   PubMed Web of Science ®Google Scholar
• Schuppan V. D., Schmidt I., Heller M. Untersuchungen zur pharmacokinetik von metroclopramid am menshen. Arzneim-Forsch. /Drug Res. 1979; 29: 151
   PubMedGoogle Scholar
• Bakke O. M., Segura J. The absorption and elimination of metoclopramide in three animal species. J. Pharm. Pharmacol. 1976; 28: 32
   PubMed Web of Science ®Google Scholar
• Dedrick R. L. Animal scale up. Pharmacology and Pharmacokinetics, T. Teorell, R. L. Dedrick, P. G. Condliffe. Plenum Press, New York 1974; 117
   Google Scholar
• Yakatan G. J., Maness D. D., Scholler J., Johnston J. T., Novick W. J., Doluisio J. T. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses. Res. Commun. Chem. Pathol. Pharmacol. 1979; 24: 465
   PubMedGoogle Scholar
• Ehrnebo M. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration. J. Pharm. Sci. 1974; 63: 1114
   PubMed Web of Science ®Google Scholar
• Davis L. E., Baggot J. D., Davis C. A. N., Powers T. E. Elimination kinetics of pentobarbital in nephrectomised dogs. Am. J. Vet. Res. 1973; 34: 231
   PubMed Web of Science ®Google Scholar
• El-Sayed M. G. A., Atef M., El-Gendi A. Y. I., Youssef S. A. H. Disposition kinetics of furosemide in dogs. Arch. Int. Pharmacodyn. 1981; 253: 4
   PubMedGoogle Scholar
• Duggan D. E., Kwan K. C. Enterohepatic recirculation of drugs as a determinant of therapeutic ratio. Drug Metab. Rev. 1979; 9: 21
   PubMed Web of Science ®Google Scholar
• Domenech J., Lauroba J., Moreno J., Pla-Delfina J. M. A relationship between biological half-life and effective half-life according to pharmacological responses in non-steroid anti-inflammatory drugs. Arzneim-Forsch. /Drug Res. 1981; 31: 445
   PubMed Web of Science ®Google Scholar
• Andreasen F., Mikkelsen E. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur. J. Clin. Pharmacol. 1977; 12: 15
   PubMed Web of Science ®Google Scholar
• Wallin J. D., Ryals P., Kaplowitz N. Metabolic clearance of furosemide in the rat. J. Pharm. Exp. Ther. 1977; 200: 52
   PubMed Web of Science ®Google Scholar
• Roberts S. M., Levy G. Pharmacokinetic studies on propoxyphene. IV. Effect of renal failure on systemic clearance in rats. J. Pharm. Sci. 1980; 69: 363
   PubMed Web of Science ®Google Scholar
• Smith D. A., Neale M. G. Metabolism and clearance of proxicromil, studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man. Eur. J. Drug Metab. Pharmacokinet 1983, to be published
   PubMed Web of Science ®Google Scholar
• Smith D. A. Unpublished observations 1980
   Google Scholar
• Nation R. L. Drug kinetics in childbirth. Clin. Pharmacokinet. 1980; 5: 340
   PubMed Web of Science ®Google Scholar
• Dahlstrom B. E., Paalzow L. K., Lindberg C., Bogentoft C. Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat. Drug Metab. Disp. 1979; 7: 108
   PubMed Web of Science ®Google Scholar
• Smith D. A. Differences in toxicity due to species variation in the metabolism of an oral anti-allergy agent. Br. J. Pharmacol. 1979; 66: 422P
   PubMed Web of Science ®Google Scholar
• McManus M. E., Ilett K. F. Comparison of rate of hepatic metabolismin vitro and half-life for antipyrinein vivo in three species. Xenobiotica 1979; 9: 107
   PubMed Web of Science ®Google Scholar
• Gladigau V. V., Voltman K. O. Description of the pharmacokinetic behaviour of etozolin and its main metabolite. Arzneim-Forsch/Drug Res. 1977; 27: 1786
   PubMed Web of Science ®Google Scholar
• Aungst B. J., Veseel E. S., Shapiro I. R. Unusual characteristics of the dose dependent uptake of propylthiouracil by thyroid gland. in vivo, Biochem. Pharmacol. 1979; 28: 1479
   PubMed Web of Science ®Google Scholar
• Swanson B. N., Frolik C. A., Zaharevitz D. W., Roller P. P., Sporn M. B. Dose dependent kinetics of all-trans-retinoic acid in rats. Biochem. Pharmacol. 1981; 30: 107
   PubMed Web of Science ®Google Scholar
• Sweatman T. W., Renwick A. G. The tissue distribution and pharmacokinetics of saccharin in the rat. Toxicol. Appl. Pharmacol. 1980; 55: 18
   PubMed Web of Science ®Google Scholar
• Venkataramanan R., Axelson J. E. Dose dependent pharmacokinetics of tocainide in the rat. J. Pharm. Exp. Ther. 1980; 215: 231
   PubMed Web of Science ®Google Scholar
• Marre R., Freiesleben H. Antimicrobial agents in rats, serum levels of parenteral cephalosporins. Arzneim-Forsch./Drug Res. 1979; 29: 932
   PubMed Web of Science ®Google Scholar
• Smyth R. D., Hottendorf G. H. Application of pharmacokinetics and biopharmaceutics in the design of toxicological studies. Toxicol. Appl. Pharmacol. 1980; 53: 179
   PubMed Web of Science ®Google Scholar
• Latini R., Bonati M., Castelli D., Garattini S. Dose dependent kinetics of caffeine in rats. Toxicol. Lett. 1978; 2: 267
   Web of Science ®Google Scholar
• Miller R. P., Rotenberg K. S., Adir J. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab. Disp. 1977; 5: 436
   PubMed Web of Science ®Google Scholar
• Constantin M., Pognat J. F. Pharmacokinetics of amitrexine in the dog. Arzneim-Forsch./Drug Res. 1978; 28: 646
   PubMedGoogle Scholar
• Konishi M., Agoh T., Sato T., Konaka R., Mori Y. Metabolism and disposition of peptidoaminobenzophenone (2-O-chlorobenzoyl-4-chloro-n-methyl-N′-glycylglycinanilide) and its major benzodiazepine metabolites in dogs. Drug Metab. Disp. 1979; 8: 253
   Web of Science ®Google Scholar
• Eason C. T., Clark B., Smith D. A., Parke D. V. The mechanism of hepatotoxicity of a chromone carboxylic acid in the dog. Xenobiotica 1982; 12: 155
   PubMed Web of Science ®Google Scholar
• Sasahara K., Nitanai T., Habara T., Morioka T., Nakajima E. Dosage form design for improvement of bioavailability of levodopa. II. Bioavailability of marketed levodopa preparations in dogs and Parkinsonian patients. J. Pharm. Sci. 1980; 69: 261
   PubMed Web of Science ®Google Scholar
• Ishigami M., Sabouromaru K., Niino K., Kido M., Morita S., Miyamoto G., Kohri H. Pharmacokinetics of procaterol in the rat, rabbit and beagle dog. Arzneim-Forsch./Drug Res. 1979; 25: 266
   Google Scholar
• Gibson T. P., Nelson H. A. Digoxin alters quinidine and quinidine alters digoxin pharmacokinetics in dogs. J. Lab. Clin. Med. 1980; 95: 417
   PubMed Web of Science ®Google Scholar
• Jaillon P., Kates R. E. Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogs. J. Pharmacol. Exp. Ther. 1980; 213: 33
   PubMed Web of Science ®Google Scholar
• Loscher W., Esenwein H. Pharmacokinetics of sodium valproate in dog and mouse. Arzneim-Forsch./Drug Res. 1978; 28: 782
   PubMed Web of Science ®Google Scholar
• Laufen V. H., Juhran W., Fleissig W., Gotz R., Scharpf F., Bartsch G. On the pharmacokinetics of vincamine after i.v. and oral application to the dog. Arzneim-Forsch/Drug Res. 1977; 27: 1255
   PubMedGoogle Scholar
• Kienel V. G. Comparison between the pharmacokinetics of epicillin and ampicillin. Arzneim-Forsch/Drug Res. 1976; 26: 781
   PubMed Web of Science ®Google Scholar
• Ladefoget O. The effect of carbon tetrachloride (CCL4) induced liver damage on the volume of distribution, the elimination half-life and body clearance of antipyrine and warfarin in rabbits. Acta Vet. Scand. 1979; 20: 429
   PubMed Web of Science ®Google Scholar
• Ahmad R. A., Rogers H. J. Non-linear pharmacokinetic behaviour of dapsone in the rabbit. J. Pharm. Pharmacol. 1981; 33: 547
   PubMed Web of Science ®Google Scholar
• Fukuchi S., Katayama K., Kakemi M., Ueda M., Koizumi T. Biological effects of furosemide in relation to its disposition in rabbits. Chem. Pharm. Bull. 1977; 25: 2217
   PubMed Web of Science ®Google Scholar
• Bloedow D. C., Ralston D. H., Hargrove J. C. Lidocaine pharmacokinetics in pregnant and nonpregnant sheep. J. Pharm. Sci. 1980; 69: 32
   PubMed Web of Science ®Google Scholar
• Madsen S. M., Ribel U. Pharmacokinetics of theophylline and 3-methylxanthine in guinea pigs. Acta Pharmacol. Toxicol. 1981; 48: 1
   PubMedGoogle Scholar
• McAllister W. A. C., Winfield C. R., Collier J. V. Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose. Eur. J. Clin. Pharmacol. 1981; 20: 141
   PubMed Web of Science ®Google Scholar
• Doluisio J. T., Lapiana J. C., Dittert L. W. Pharmacokinetics of ampicillin trihydrate, sodium ampicillin and sodium dicloxacillin following intramuscular injection. J. Pharm. Sci. 1971; 60: 715
   PubMed Web of Science ®Google Scholar
• Jusko W. J., Rose J. Q. Monitoring prednisone and prednisolone. Ther. Drug Monitoring 1980; 2: 169
   PubMed Web of Science ®Google Scholar
• Clark B., Smith D. A. An Introduction to Pharmacokinetics. Blackwell Scientific, Oxford 1981
   Google Scholar
• Ramzan M. I., Triggs E. J., Shanks C. A. Pharmacokinetic studies in man with gallamine triethiodide. Eur. J. Clin. Pharmacol. 1980; 17: 135
   PubMed Web of Science ®Google Scholar
• Casarelt L. J., Doull J. Toxicology, the Basic Science of Poisons. Macmillan, New York 1975, chap. 5
   Google Scholar
• Sioufi A., Colussi D., Caudal F., Schoeller J. P., Massias P. Pharmacokinetics of phenylbutazone in healthy subjects after oral administration of single and multiple doses. J. Pharm. Sci. 1980; 69: 1413
   PubMed Web of Science ®Google Scholar
• Tanner A., Bocher F., Caffin J., Halliday J., Powell L. Dose dependent prednisolone kinetics. Clin. Pharm. Ther. 1979; 25: 571
   PubMed Web of Science ®Google Scholar
• Galinsky R. E., Levy G. Dose- and time-dependent elimination of acetominophen in rats: pharmacokinetic implications of cosubstrate depletion. J. Pharm. Exp. Ther. 1981; 219: 14
   PubMed Web of Science ®Google Scholar
• Price Evans D. A. Human pharmacogenetics. Drug Metabolism from Microbe to Man, D. V. Parke, R. L. Smith. Taylor & Francis, London 1977; 369
   Google Scholar
• Caldwell J., Davies S., Smith R. L. Inter-individual differences in the conjugation of paracetamol with glucuronic acid and sulphate. Br. J. Pharmacol. 1980; 70: 112P
   Web of Science ®Google Scholar
• Eichelbaum M., Spannbrucker N., Steineke B., Dengler H. J. Defective N-oxidation of sparteine in man: a new pharmacogenetic effect. Eur. J. Clin. Pharmacol. 1979; 16: 183
   PubMed Web of Science ®Google Scholar
• Singlas E., Goujet M. A., Simon P. Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathy. Eur. J. Clin. Pharmacol. 1978; 14: 195
   PubMed Web of Science ®Google Scholar
• Blaschke T. F. Protein binding and kinetics of drugs in liver diseases. Clin. Pharmacokinet. 1977; 2: 32
   PubMed Web of Science ®Google Scholar
• Belpaire F. M., Bogaert M. G., Mussche M. M. Influence of acute renal failure on the protein binding of drugs in animals and in man. Eur. J. Clin. Pharmacol. 1977; 11: 27
   PubMed Web of Science ®Google Scholar
• Guentert T. W., Oie S. Effect of plasma protein binding on quinidine kinetics in the rabbit. J. Pharm. Exp. Ther. 1980; 215: 165
   PubMed Web of Science ®Google Scholar
• Yu H. Y., Sawada Y., Sugiyama Y., Iga T., Hanano M. Effect of sulfadimethoxine on thiopental distribution and elimination in rats. J. Pharm. Sci. 1981; 70: 323
   PubMed Web of Science ®Google Scholar
• Richey D. P., Bender A. D. Pharmacokinetic consequences of ageing. Ann. Rev. Pharmacol. Toxicol. 1977; 17: 49
   PubMed Web of Science ®Google Scholar
• Hulse M., Feldman S., Bruckner J. V. Effect of blood sampling schedules on protein drug binding in the rat. J. Pharm. Exp. Ther. 1981; 218: 416
   PubMed Web of Science ®Google Scholar
• Walker C. H. Species differences in microsomal monooxygenase activity and their relationship to biological half-lives. Drug Metab. Rev. 1978; 7: 295
   PubMed Web of Science ®Google Scholar
• Brodie B. B., Reid W. D. Some pharmacological consequences of species variation in rates of metabolism. Fed. Proc. 1967; 6: 1062
   Google Scholar
• Loftsson T., Kaminski J. J., Bodor N. Improved delivery through biological membranes. VIII. Design, synthesis andin vivo testing of prodrugs of aspirin. J. Pharm. Sci. 1981; 70: 743
   PubMed Web of Science ®Google Scholar
• Rowland M., Riegelman S. Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. J. Pharm. Sci. 1968; 57: 1313
   Web of Science ®Google Scholar
• Kaneniwa N., Hiura M., Nakagawa S. Effect of lipid solubility and dose on the elimination of barbiturates in rabbits. Chem. Pharm. Bull. 1979; 27: 1501
   PubMed Web of Science ®Google Scholar
• Ohnhaus E. E., Thorgeirsson S. S., Davies D. S., Breckenridge A. Changes in liver blood flow during enzyme induction. Biochem. Pharmacol. 1971; 20: 2561
   PubMed Web of Science ®Google Scholar
• Denis P., Ossenberg F. W., Benhamou J. P. Hepatic blood flow and enzyme induction in the rat. Biochem. Pharmacol. 1975; 24: 249
   PubMed Web of Science ®Google Scholar
• Nies A. S., Wilkinson G. R., Rush B. D., Strother J. R., McDevitt D. G. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. Biochem. Pharmacol. 1991; 25, 1976
   Google Scholar
• Rappoport A. M. Physioanatomical basis of toxic liver injury. Toxic Injury of the Liver, E. Farber, M. M. Fisher. Marcel Dekker, New York 1979; 1, Part A
   Google Scholar
• Heywood R. Target organ toxicity. Toxicol. Lett. 1981; 8: 349
   PubMed Web of Science ®Google Scholar
• Peto R., Pike M. C., Day N. E., Gray R. G., Lee P. N., Parish S., Peto J., Richards S., Wahrendorf J. IARC Monogr. Long-Term and Short-Term Screening Assays for Carcinogens: a Critical Appraisal. IARC, Lyon 1980; 311, Suppl. 2
   Google Scholar
• Sladek N. E., Domeyer B. E., Merriman R. L., Brophy G. T. Differential effects of Walker 256 carcinosarcoma cells growing subcutaneously, intramuscularly, or intraperitoneally on hepatic microsomal mixed function oxygenase activity. Drug Metab. Disp. 1978; 6: 412
   PubMed Web of Science ®Google Scholar
• Balant L. P., McAinsh J. Use of metabolite data in the evaluation of pharmacokinetics and drug action. Concepts in Drug Metabolism, P. Jenner, B. Testa. Marcel Dekker, New York 1980; 311
   Google Scholar
• Migdalof B. H., Yorgey K. A., Popkave C. G. The time course of tolmetin and its metabolites in the plasma of individual rats and mice. Drug Metab. Disp. 1976; 4: 468
   PubMed Web of Science ®Google Scholar
• Chanoine F., Benedetti M. S., Ancher J. F., Dostert P. Absorption, distribution, elimination and metabolism of14C-heptaminol hydrochloride in rat. Arzneim-Forsch./Drug Res. 1981; 31: 1430
   PubMed Web of Science ®Google Scholar
• Smyth R. D., Van Harken D. R., Pfeffer M., Nardella P. A., Vasiljev M., Pinto J. S., Hottendorf G. H. Biological disposition of 8-methoxsalen in rat and man. Arzneim. Forsch./Drug Res. 1980; 30: 1725
   PubMed Web of Science ®Google Scholar
• Hucker H. B., Stauffer S. C., White S. D., Rhodes R. E., Arison B. H., Umbenhauer E. R., Bower R. J., McMahon F. G. Physiologic disposition and metabolic fate of a new anti inflammatory agentcis-5-fluoro-2-methyl-1-[p-(methylsulfinyl)-benzlidenyl]-indene-3-acetic acid in the rat, dog, rhesus monkey and man. Drug Metab. Disp. 1973; 1: 721
   PubMed Web of Science ®Google Scholar
• Dain J. G., Bhuta S. I., Coombs R. A., Talbot K. C., Duggar H. A. Metabolism of butalbital, 5-allyl-5-isobutyl barbituric acid in the dog. Drug Metab. Disp. 1980; 8: 247
   PubMed Web of Science ®Google Scholar
• Cayen M. N., Kraml M., Robinson W. T., Dvornik D. Disposition of furobufen in mice, rats, dogs and man. Drug Metab. Disp. 1981; 9: 119
   PubMed Web of Science ®Google Scholar
• Dieterle W., Faigle J. W. Species differences in the disposition and metabolism of sulfinpyrazone. Xenobiotica 1981; 11: 559
   PubMed Web of Science ®Google Scholar
• Wilson A. G. E., Pickett R. D., Eling T. E., Anderson M. W. Studies on the persistence of basic amines in the rabbit lung. Drug Metab. Disp. 1979; 7: 420
   PubMed Web of Science ®Google Scholar
• Abernathy D. R., Greenblatt D. J., Divoll M., Harmatz J. S., Shader R. I. Alterations in drug distribution and clearance due to obesity. J. Pharm. Exp. Ther. 1981; 217: 681
   PubMed Web of Science ®Google Scholar
• Smith D. A., Fisher A. N. Age related changes in the clearance and oral absorption of sodium cromoglycate in the developing albino rat. J. Pharm. Pharmacol. 1980; 32: 823
   PubMed Web of Science ®Google Scholar
• Fisher A. N., Smith D. A. Interpretation of clearance data in experiments involving bodyweight changes. Abstr. Stowe School Symp. Drug Metabolism. 1982
   Google Scholar
• Collins J. M., Blake D. A., Egner P. G. Phenytoin metabolism in the rat. Drug Metab. Disp. 1978; 6: 251
   PubMedGoogle Scholar
• Smith D. A. Unpublished observations 1982
   Google Scholar
• Smith R. L. Species differences in the biliary excretion of drugs. Proc. Eur. Soc. Study Drug Toxicol. 1970; 11: 19
   Google Scholar
• Levine W. G. Biliary excretion of drugs and other xenobiotics. Ann. Rev. Pharmacol. Toxicol. 1978; 18: 81
   PubMed Web of Science ®Google Scholar
• O'Flaherty E. J. Toxicants and Drugs, Kinetics and Dynamics. John Wiley & Sons, New York 1981
   Google Scholar
• Dixon B. A., Caldwell J., Smith R. L. Metabolism of arylacetic acids. II. The fate of [14C] hydratropic acid and its variation with species. Xenobiotica 1977; 7: 695
   PubMed Web of Science ®Google Scholar
• Mehta R., Hirom P. C., Milburn P. The influence of dose on the pattern of conjugation of phenol and 1-napthol in nonhuman primates. Xenobiotica 1978; 8: 445
   PubMed Web of Science ®Google Scholar
• Hall B. E., James S. P. Some pathways of xenobiotic metabolism in the adult and neonatal marmoset (. Callithrix jacchus), Xenobiotica 1980; 10: 421
   PubMed Web of Science ®Google Scholar
• Koster H., Halsema I., Scholtens E., Knippers M., Mulder G. J. Dose dependent shifts in the sulfation and glucuronidation of phenolic compounds in the ratin vivo and in isolated hepatocytes. The role of saturation of phenolsulfotransferases. Biochem. Pharmacol. 1981; 30: 2569
   PubMed Web of Science ®Google Scholar
• Spector W. S. Acute toxicities. Handbook of Toxicology. W. B. Saunders, Philadelphia 1956; Vol. 1
   Google Scholar
• Klaassen C. D., Strom S. C. Comparison of biliary excretory function and bile composition in male, female and lactating female rats. Drug Metab. Disp. 1978; 6: 120
   PubMed Web of Science ®Google Scholar
• Eason C. T. The Mechanism of Hepatotoxicity of an Anti-Allergy Compound, Ph.D. thesis. University of Surrey, SurreyU.K. 1981
   Google Scholar
• Wheldrake J. F., Hawke D., Baudinette R. V. Mixed function oxidase activity in a desert rodent. Notomys alexis, Xenobiotica 1979; 9: 565
   PubMed Web of Science ®Google Scholar
• Green T. P., Mirkin B. L. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion. J. Pharm. Exp. Ther. 1981; 218: 122
   PubMed Web of Science ®Google Scholar
• Altman P. L., Dittmer D. S. Biological handbooks. Blood and Other Body Fluids. American Society for Experimental Biology, Newark, N.J. 1971; 363–409
   Google Scholar
• Thornton P. C., Wright P. A., Sacra P. J., Goodier T. E. W. The ferretMustela putorius furo, as a new species in toxicology. Lab. Anim. 1979; 13: 119
   PubMedGoogle Scholar
• Cornelius C. E. Rates of chloresis in various species. Am. J. Dig. Dis. 1976; 21: 426
   PubMedGoogle Scholar
• Boyd E. M., Dolman M., Knight L. M., Sheppard E. P. The chronic oral toxicity of caffeine. Can. J. Physiol. Pharmacol. 1965; 43: 995
   Web of Science ®Google Scholar
• Boyd E. M., Jarzylo S. V. Daily oral doses of pilocarpine tolerated by albino rats. Arch. Int. Pharmacodyn. Ther. 1968; 175: 84
   PubMedGoogle Scholar
• Boyd E. M. Analgesic abuse: maximal tolerated daily doses of acetylsalicyclic acid. Can. Med. Assoc. J. 1968; 99: 790
   PubMed Web of Science ®Google Scholar
• Chan P. K., Reddy C. S., Hayes A. W. Acute toxicity of penicillic acid and its interaction with pentobarbital and other compounds. Toxicol. Appl. Pharmacol. 1980; 52: 1
   PubMed Web of Science ®Google Scholar
• Tattersall M. L. Statistics and the LD50. Arch. Toxicol. 1982; 267, Suppl 5
   PubMedGoogle Scholar
• Litchfield J. T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949; 96: 99
   PubMed Web of Science ®Google Scholar
• Alder S., Janton C., Zbinden G. Preclinical Safety Requirements in 1980. Institute of Toxicology, Zurich 1981
   Google Scholar
• Kimura E. T., Tekeli S., Lewkowski J. P., Majors K. R., Kestenson J. W. Acute and subacute toxicity studies with fortimicin A sulphate (Abbott - 44747), a new aminoglycoside antibiotic. Toxicol. Appl. Pharmacol. 1980; 53: 399
   PubMed Web of Science ®Google Scholar
• Chou B. J., Mir G. N., Brown W. R., Rapp W. R., Yelnosky J. Toxicity studies on lidomidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Arzneim-Forsch./Drug Res. 1978; 28: 1471
   PubMed Web of Science ®Google Scholar
• Herman V. M., Wiegleb J., Leuschner F. Toxicological studies on etozolin. Arzneim-Forsch./Drug Res. 1977; 27: 1758
   PubMed Web of Science ®Google Scholar
• Gerber N., Weller W. L., Lynn R., Rango R. E., Sweetman B. J., Bush M. J. Study of dose dependent metabolism of 5,5-diphenyl hydantoin in the rat using new methodology for isolation and quantitation of metabolitesin vivo and. in vitro, J. Pharmacol. Exp. Ther. 1971; 178: 567
   PubMed Web of Science ®Google Scholar
• Stella V. J., Chu C. K. Effect of short term exposure to polychlorinated biphenyls on pharmacokinetics of intravenous pentobarbital in rats. J. Pharm. Sci. 1980; 69: 1274
   PubMed Web of Science ®Google Scholar
• Aldridge A., Niems A. H. The effects of phenobarbital and β-napthoflavone on the elimination kinetics and metabolite pattern of caffeine in the beagle dog. Drug Metab. Disp. 1979; 7: 378
   PubMed Web of Science ®Google Scholar
• Yacobi A., Slattery J. T., Levy G. Comparative pharmacokinetics of coumarin anticoagulants. J. Pharm. Sci. 1980; 69: 634
   PubMed Web of Science ®Google Scholar
• Gillette J. R. Kinetic aspects of metabolism and elimination of foreign compounds in animals. Enzymatic Basis of Detoxication, W. B. Jakoby. Academic Press, New York 1980; Vol. 1: 9
   Google Scholar
• Vessel E. S. Genetic and environmental factors affecting drug disposition in man. Clin. Pharmacol. Ther. 1977; 22: 659
   PubMed Web of Science ®Google Scholar
• Levy G. Pharmacokinetics in renal disease. Am. J. Med. 1977; 62: 461
   PubMed Web of Science ®Google Scholar
• Klotz U. Influence of liver disease on the elimination of drugs. Eur. J. Drug Metab. Pharmacokinet. 1978; 3: 129
   Google Scholar
• Williams R. L., Benet L. Z. Drug pharmacokinetics in cardiac and hepatic disease. Ann. Rev. Pharmacol. Toxicol. 1980; 20: 389
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Pang K. S. Theoretic aspects of pharmacokinetic drug interactions. Clin. Pharmacol. Ther. 1977; 22: 623
   PubMed Web of Science ®Google Scholar
• Chatfield D. H., Green J. N. Disposition and metabolism of benoxaprofen in laboratory animals and man. Xenobiotica 1978; 8: 133
   PubMed Web of Science ®Google Scholar
• Kensler C. J. Experimental procedures in the evaluation of chemical carcinogens. Regulatory Aspects of Carcinogens and Food Additives—The Delaney Clause, F. Coulston. Academic Press, New York 1979; 239
   Google Scholar
• Skone-James S. G. Carcinogenicity studies on di(2-ethylhexyl) adipate. Bibra Bull. 1981; 20(5)237
   Google Scholar
• Kraybill H. F. By appropriate methods: the Delaney clause. Regulatory Aspects of Carcinogens and Food Additive—The Delaney Clause, F. Coulston. Academic Press, New York 1979; 61
   Google Scholar
• Nies A. S., Shand D. G., Wilkinson G. R. Altered hepatic blood flow and drug disposition. Clin. Pharmacokinet. 1976; 1: 135
   PubMedGoogle Scholar
• Welling P. G. Drug kinetics. Foreign Compound Metabolism in Mammals. The Chemical Society, London 1975; Vol. 3: 107
   Google Scholar
• Brown S. S. Kinetics of absorption, distribution and excretion. Foreign Compound Metabolism in Mammals. The Chemical Society, London 1970; Vol. 1: 98
   Google Scholar
• Katchem B., Buxbaum S., Meyer J., Ning J. Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino)nicotinic acid (lonixin) in rats, dogs and monkeys. J. Pharm. Exp. Ther. 1973; 184: 453
   PubMed Web of Science ®Google Scholar
• Stohs S. J., Al-Turk W. A., Angle C. R. Glutathione- S-transferase and glutathione reductase in hepatic and extrahepatic tissues of female mice as a function of age. Biochem. Pharmacol. 1982; 31: 2113
   PubMed Web of Science ®Google Scholar
• Kitani K., Kanai S., Miu R., Morita Y., Kashara M. The effect of ageing on the biliary excretion of ouabain in the rat. Exp. Geront. 1978; 13: 9
   PubMed Web of Science ®Google Scholar
• Kato R., Takanaka A. The effect of phenobartitone on electron transport system, oxidation and reduction of drugs in liver microsomes of rats of different ages. J. Biochem. 1968; 63: 406
   PubMed Web of Science ®Google Scholar
• Schmucker D. L., Wang R. K. Effect of ageing and phenobarbital on the rat liver microsomal drug-metabolising system. Mech. Ageing Dev. 1981; 15: 189
   PubMed Web of Science ®Google Scholar
• Kato R., Vassanelli P., Frontino G., Chiesara E. Variations in the activity of the liver microsomal drug metabolising enzymes in rats in relation to age. Biochem. Pharmacol. 1964; 13: 1037
   PubMed Web of Science ®Google Scholar
• Klotz U. Effect of age on levels of diazepam in plasma and brain of rats. Nauyn-Schmiedeberg's Arch. 1979; 307: 167
   PubMed Web of Science ®Google Scholar
• Latini R., Bonati M., Manzi E., Tacconi M. T., Sadurska B., Bizzi A. Caffeine disposition and effects in young and one-year old rats. J. Pharm. Pharmacol. 1980; 32: 596
   PubMed Web of Science ®Google Scholar
• Glantz S. A., Kernoff R., Goldman R. H. Age related changes in ouabain pharmacology. Circ., Res. 1976; 39: 409
   Web of Science ®Google Scholar
• Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of debrisoquine in man. Lancet 1977; ii: 584
   Web of Science ®Google Scholar
• Inaba T., Otton S. V., Kalow W. Deficient metabolism of debrisoquine and sparteine. Clin. Pharm. Therap. 1980; 27: 547
   PubMed Web of Science ®Google Scholar
• Sloan T. P., Mahgoub A., Lanaester R., Idle J. R., Smith R. L. Polymorphism of carbon oxidation of drugs and clinical implications. Br. Med. J. 1978; 2: 655
   PubMed Web of Science ®Google Scholar
• Tucker G. T., Silas J. H., Iyun A. O., Lennard M. S., Smith A. J. Polymorphic, hydroxylation of debrisoquine. Lancet 1977; ii: 718
   Google Scholar
• Glocklin V. C. General considerations for studies of the metabolism of drugs and other chemicals. Drug Met. Rev. 1982; 13: 929
   PubMed Web of Science ®Google Scholar
• Gehring P. J., Watanabe P. G., Young J. D. The relevance of dose-dependent pharmacokinetics in the assessment of carcinogenic hazard of chemicals. The Origins of Human Cancer, Cold Spring Harbour Conference, H. H. Hiatt, J. D. Watson, J. A. Wouster. 1977; 187
   Google Scholar
• Poynter D. Problems in assessing the toxicity of inhaled drugs. Evaluation of Bronchodilator Drugs, An Asthma Research Council Symposium, D. M. Burley, S. W. Clarke, M. F. Cuthbert, J. W. Paterson, J. H. Shelly. Trust for Education and Research in Therapeutics. 1974; 167
   Google Scholar